Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

This publication has 14 references indexed in Scilit:

• Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
  Urologia Internationalis, 1998
• Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?
  British Journal of Urology, 1995
• Can Prostate-Specific Antigen Levels Predict Bone Scan Evidence of Metastases in Newly Diagnosed Prostate Cancer?
  American Journal of Clinical Oncology, 1994
• Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
  Published by American Medical Association (AMA) ,1993
• The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer
  JAMA, 1993
• Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
  JAMA, 1992
• Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer
  Journal of Urology, 1992
• The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men
  Cancer, 1991
• Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters
  Journal of Urology, 1991
• CLINICAL VALUE OF SERUM PROSTATIC ACID PHOSPHATASE DETERMINED BY RADIOIMMUNOASSAY
  The Japanese Journal of Urology, 1981